NCT04742556 2024-09-19A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)Boehringer IngelheimPhase 1 Completed15 enrolled 18 charts